SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-085882
Filing Date
2021-03-18
Accepted
2021-03-18 16:39:55
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFA14A d899103ddefa14a.htm DEFA14A 48419
2 GRAPHIC g899103g0002a.jpg GRAPHIC 827
3 GRAPHIC g899103g30m04.jpg GRAPHIC 1150
4 GRAPHIC g899103sp001a.jpg GRAPHIC 2545
5 GRAPHIC g899103sp01b.jpg GRAPHIC 52928
6 GRAPHIC g899103sp04.jpg GRAPHIC 10943
  Complete submission text file 0001193125-21-085882.txt   144643
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14956 | Film No.: 21754864
SIC: 2834 Pharmaceutical Preparations